| Product Code: ETC8545303 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Parkinsons Disease Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Parkinsons Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands Parkinsons Disease Market - Industry Life Cycle |
3.4 Netherlands Parkinsons Disease Market - Porter's Five Forces |
3.5 Netherlands Parkinsons Disease Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Netherlands Parkinsons Disease Market Revenues & Volume Share, By Medical Devices, 2021 & 2031F |
3.7 Netherlands Parkinsons Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Netherlands Parkinsons Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 Netherlands Parkinsons Disease Market Revenues & Volume Share, By Patient Care Setting, 2021 & 2031F |
4 Netherlands Parkinsons Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing aging population in the Netherlands |
4.2.2 Advancements in medical research and technology for Parkinson's disease |
4.2.3 Rising awareness and diagnosis rates for Parkinson's disease |
4.3 Market Restraints |
4.3.1 High treatment costs and limited insurance coverage |
4.3.2 Side effects and efficacy concerns related to current treatment options |
5 Netherlands Parkinsons Disease Market Trends |
6 Netherlands Parkinsons Disease Market, By Types |
6.1 Netherlands Parkinsons Disease Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Parkinsons Disease Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Netherlands Parkinsons Disease Market Revenues & Volume, By Levodopa/Carbidopa, 2021- 2031F |
6.1.4 Netherlands Parkinsons Disease Market Revenues & Volume, By Dopamine Receptor Agonists, 2021- 2031F |
6.1.5 Netherlands Parkinsons Disease Market Revenues & Volume, By MAO-Inhibitors, 2021- 2031F |
6.1.6 Netherlands Parkinsons Disease Market Revenues & Volume, By COMT-Inhibitors, 2021- 2031F |
6.1.7 Netherlands Parkinsons Disease Market Revenues & Volume, By Anticholinergics, 2021- 2031F |
6.1.8 Netherlands Parkinsons Disease Market Revenues & Volume, By Other Drugs, 2021- 2031F |
6.2 Netherlands Parkinsons Disease Market, By Medical Devices |
6.2.1 Overview and Analysis |
6.2.2 Netherlands Parkinsons Disease Market Revenues & Volume, By Deep Brain Stimulation (DBS) Devices, 2021- 2031F |
6.2.3 Netherlands Parkinsons Disease Market Revenues & Volume, By Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices, 2021- 2031F |
6.3 Netherlands Parkinsons Disease Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Netherlands Parkinsons Disease Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Netherlands Parkinsons Disease Market Revenues & Volume, By Transdermal, 2021- 2031F |
6.3.4 Netherlands Parkinsons Disease Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.3.5 Netherlands Parkinsons Disease Market Revenues & Volume, By Intestinal Infusion, 2021- 2031F |
6.3.6 Netherlands Parkinsons Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Netherlands Parkinsons Disease Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Netherlands Parkinsons Disease Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 Netherlands Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 Netherlands Parkinsons Disease Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.5 Netherlands Parkinsons Disease Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.5 Netherlands Parkinsons Disease Market, By Patient Care Setting |
6.5.1 Overview and Analysis |
6.5.2 Netherlands Parkinsons Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Netherlands Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
7 Netherlands Parkinsons Disease Market Import-Export Trade Statistics |
7.1 Netherlands Parkinsons Disease Market Export to Major Countries |
7.2 Netherlands Parkinsons Disease Market Imports from Major Countries |
8 Netherlands Parkinsons Disease Market Key Performance Indicators |
8.1 Number of clinical trials for new Parkinson's disease treatments in the Netherlands |
8.2 Percentage increase in funding for Parkinson's disease research |
8.3 Adoption rate of new technologies for Parkinson's disease management |
9 Netherlands Parkinsons Disease Market - Opportunity Assessment |
9.1 Netherlands Parkinsons Disease Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Netherlands Parkinsons Disease Market Opportunity Assessment, By Medical Devices, 2021 & 2031F |
9.3 Netherlands Parkinsons Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Netherlands Parkinsons Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.5 Netherlands Parkinsons Disease Market Opportunity Assessment, By Patient Care Setting, 2021 & 2031F |
10 Netherlands Parkinsons Disease Market - Competitive Landscape |
10.1 Netherlands Parkinsons Disease Market Revenue Share, By Companies, 2024 |
10.2 Netherlands Parkinsons Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here